Thursday, December 3 9–10am
Screen. Assess. Act. A Primary Care Approach to Alcohol Use Disorder
Wednesday, December 2 1:30–2:30pm
Cardiology Guidelines to Practice: 2026 Updates in HTN and Lipid Management
Wednesday, December 2 4:30–6pm
Conversations that Count: Building Skills to Motivate Sustainable Weight Change
Thursday, December 3 11am–12:30pm
EKGs Made Practical: Rhythms, Rates, and Red Flags for Primary Care
Thursday, December 3 2:45–3:45pm
Live Ortho Demonstration: Shoulder and Knee Exams for Primary Care
Thursday, December 3 1:30–2:30pm
Artifact or Alarm? Deciphering Common Incidental Lab Findings and When to Escalate
Thursday, December 3 3:45–4:45pm
The Honeymoon is Over: The Return of International Pathogens to Your Waiting Room
Wednesday, December 2 8:30–9:30am
Rash Decisions: Recognizing and Managing Common Skin Conditions
Wednesday, December 2 7:30–8:30am
AI - The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)
Thursday, December 3 11am–12:30pm
EKGs Made Practical: Rhythms, Rates, and Red Flags for Primary Care
Thursday, December 3 8–9am
Decoding Elevated LFTs: When to Worry, When to Watch, When to Refer
Wednesday, December 2 11:30am–12:30pm
Gut Club: Advances in Irritable Bowel Syndrome and Colorectal Cancer Screening
Wednesday, December 2 10:30–11:30am
Wednesday, December 2 4:30–6pm
Conversations that Count: Building Skills to Motivate Sustainable Weight Change
Thursday, December 3 9–10am
Screen. Assess. Act. A Primary Care Approach to Alcohol Use Disorder
Earn CME/CE credits in Phoenix.
Register NowDisclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- James Besante, MD
- No relevant financial relationships disclosed.
- Rachel M. Bond, MD, FACC
- Information to come
- Anna Beth Bradley, MD
- No relevant financial relationships disclosed.
- Andrew E. Budson, MD
- Information to come
- Bethany Doerfler, MS, RDN
- No relevant financial relationships disclosed.
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Consultant: OptumRx
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Lawrence Herman, DMSc, MPA, PA-C, DFAAPA
- Consultant: Novo Nordisk; Speaker: Novo Nordisk
- Jonette Keri, MD, PhD
- Information to come
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GSK, HLS Therapeutics, Medexus, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Reckitt, Sanofi
- Vani Potluri, MD, DABOM
- Information to come
- Sammy Saab, MD, MPH, AGAF, FACG, FAASLD
- Information to come
- Philip Schoenfeld, MD, MSEd, MSc
- Speaker: Ardelyx Pharmaceuticals; Advisor: Exact Sciences, Ardelyx Pharmaceuticals; Consultant: Ironwood Pharmaceuticals, AbbVie Pharmaceuticals
- Charles Vega, MD, FAAFP
- Information to come
- Shirah Vollmer, MD
- No relevant financial relationships disclosed., No relevant financial relationships disclosed.
Other Disclosures
Ty Gluckman, MD, MHA (Moderator): Consultant for OptumRx
Pamela Kushner, MD, FAAFP (Reviewer): Advisor and Speaker: AstraZeneca, Boehringer Ingelheim, GSK, Haleon, Lilly, Novo Nordisk, and Phathom Pharmaceuticals; Advisor and Stock Holder for Abbott; Advisor for Currax Pharmaceuticals, Salix/Bausch, and Verdiva Bio; Speaker for Bayer and Corcept Therapeutics.
All relevant relationships have been mitigated by Pri-Med Institute. All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.